Abbott Laboratories' medical devices business is driving segment growth while pursuing a major $21 billion acquisition.
1 report, 1 independent
Updated Sep 8
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Abbott Laboratories' medical devices business is driving segment growth while pursuing a major $21 billion acquisition.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Abbott Laboratories
American global health care and medical device products company
Related events
- Abbott Laboratories and Medtronic plc operate within the healthcare device sector.
- Abbott Laboratories and Medtronic are both identified as dividend-paying stocks.
- Abbott Laboratories acquired Exact Sciences, a company specializing in cancer diagnostics, in a move that also involved competition in the medical device market.